Dicyclohexylcarbodiimide → (RS)-2-[5-(2,3-Dichloro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-piperidine-1-carboxylic acid tert butyl ester
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH2:11][CH2:10][CH:9]1[CH2:14][C:15]([OH:17])=O)=[O:7])([CH3:4])([CH3:3])[CH3:2].[Cl:18][C:19]1[C:24]([Cl:25])=[CH:23][CH:22]=[CH:21][C:20]=1[C:26]1NN=[N:28][N:27]=1.C1(N=C=NC2CCCCC2)CCCCC1>>[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH2:11][CH2:10][CH:9]1[CH2:14][C:15]1[O:17][C:26]([C:20]2[CH:21]=[CH:22][CH:23]=[C:24]([Cl:25])[C:19]=2[Cl:18])=[N:27][N:28]=1)=[O:7])([CH3:2])([CH3:3])[CH3:4]Participants
4
Procedure
The title compound (0.70 g) was prepared from 2-carboxymethyl-piperidine-1-carboxylic acid tert butyl ester (1.13 g), 5-(2,3-dichlorophenyl)tetrazole (1.0 g) and dicyclohexylcarbodiimide (0.98 g) according to the method of description 1.
Sources & evidence
- ORD record
- ord-65f9041061d6412d9a7c536d9ad6519a
- Source dataset
- uspto-grants-2011_05
- Patent number
- US07943645B2
Reaction notes
Loading…